Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Blanke

Showing results (21-30 of 190) with videos related to

Pageof 19
Sort By:
JAMA Oncology|July 24, 2015
Chemotherapy Near the End of Life: First--and Third and Fourth (Line)--Do No HarmCharles D Blanke, Erik K Fromme
Seminars in Oncology|October 5, 2015
Progress and Infrastructure for Improved Patient Outcomes of the National Cancer Institute Network GroupsC D Blanke, Walter J Curran
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
Gastrointestinal stromal tumors and the evolution of targeted therapyRachel E Sanborn, Charles D Blanke
Journal of Medical Economics|November 12, 2010
Cost effectiveness of tyrosine kinase inhibitor therapy in metastatic gastrointestinal stromal tumorsCharles D Blanke, Daniel M Huse
Seminars in Oncology|December 22, 1999
Topoisomerase I inhibitors in the treatment of colorectal cancerM L Rothenberg, C D Blanke
Current Opinion in Oncology|March 1, 1995
Combined modality therapy in non-small cell lung cancerC D Blanke, D H Johnson
Current Treatment Options in Oncology|October 13, 2006
Gastrointestinal stromal tumors: imatinib and beyondIan D Schnadig, Charles D Blanke
Medical & Biological Engineering & Computing|April 15, 2003
Spanning set defines variability in locomotive patternsM J Kurz, N Stergiou, D Blanke
Oncology (Williston Park, N.Y.)|November 7, 1999
The role of UFT in combined-modality therapyC D Blanke, M Teng, H Choy
Archives of Physical Medicine and Rehabilitation|June 1, 1982
Flexibility training: ballistic, static or proprioceptive neuromuscular facilitation?S P Sady, M Wortman, D Blanke
Pageof 19

Showing results (21-30 of 190) with videos related to

Sort By:
Pageof 19
JAMA Oncology|July 24, 2015
Chemotherapy Near the End of Life: First--and Third and Fourth (Line)--Do No HarmCharles D Blanke, Erik K Fromme
Seminars in Oncology|October 5, 2015
Progress and Infrastructure for Improved Patient Outcomes of the National Cancer Institute Network GroupsC D Blanke, Walter J Curran
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
Gastrointestinal stromal tumors and the evolution of targeted therapyRachel E Sanborn, Charles D Blanke
Journal of Medical Economics|November 12, 2010
Cost effectiveness of tyrosine kinase inhibitor therapy in metastatic gastrointestinal stromal tumorsCharles D Blanke, Daniel M Huse
Seminars in Oncology|December 22, 1999
Topoisomerase I inhibitors in the treatment of colorectal cancerM L Rothenberg, C D Blanke
Current Opinion in Oncology|March 1, 1995
Combined modality therapy in non-small cell lung cancerC D Blanke, D H Johnson
Current Treatment Options in Oncology|October 13, 2006
Gastrointestinal stromal tumors: imatinib and beyondIan D Schnadig, Charles D Blanke
Medical & Biological Engineering & Computing|April 15, 2003
Spanning set defines variability in locomotive patternsM J Kurz, N Stergiou, D Blanke
Oncology (Williston Park, N.Y.)|November 7, 1999
The role of UFT in combined-modality therapyC D Blanke, M Teng, H Choy
Archives of Physical Medicine and Rehabilitation|June 1, 1982
Flexibility training: ballistic, static or proprioceptive neuromuscular facilitation?S P Sady, M Wortman, D Blanke
Pageof 19